Get real time updates directly on you device, subscribe now.
DocPharma has raised $2 million in a Pre-Series A funding round led by Equentis. Existing investor 100Unicorns also joined the round, along with Vinners and a group of strategic angel investors.
The Bengaluru-based healthcare supply chain startup is trying to solve a very practical problem. People want medicines quickly, but healthcare delivery cannot work like normal quick commerce. Medicines need correct prescriptions, proper storage, verified supply, and licensed fulfilment centres. DocPharma is building its business around that gap.
What DocPharma does
DocPharma is a B2B2C healthcare quick-commerce and supply chain platform. In simple words, it helps e-pharmacies, hospitals, insurers, wellness brands, doctors and healthcare platforms deliver medicines and health products faster.
The company uses a network of dark stores, partnered pharmacies and diagnostic partners. A dark store is not a regular shop for walk-in customers. It is a small fulfilment centre built to process online orders quickly.
For example, if a patient orders medicine through an e-pharmacy partner, DocPharma’s system can route the order to the nearest compliant fulfilment centre. This helps reduce delivery time and improves medicine availability.
Founder and founding year
DocPharma was founded in 2024. The company’s leadership team includes Shashank Rai, co-founder and CEO; Saqib Ali, co-founder and CBO; and Sagar Chauhan, co-founder and CPTO.
The founding team brings experience across supply chain, healthcare, technology and business growth. This is useful because healthcare logistics needs both operational discipline and strong software.
Aim of the startup
DocPharma’s aim is to make healthcare supply faster, safer and more organized.
The company has built a proprietary SaaS platform that brings warehouse management, inventory intelligence, order management and fulfilment into one system. SaaS simply means software that businesses can use online instead of building everything from scratch.
Its platform gives real-time inventory visibility, supports prescription-compliant processing, and helps route orders to the nearest fulfilment point. This matters because a medicine order should not fail after the customer has already paid or uploaded a prescription.
Purpose of the funding
The fresh $2 million funding will be used to build 100 new compliant and licensed dark stores. DocPharma also plans to expand into newer cities and strengthen its infrastructure.
This is a sensible use of capital because medicine delivery depends heavily on location. A platform cannot promise fast delivery from one large warehouse far away. It needs smaller, closer, legally compliant fulfilment points.
The company says its model can enable delivery of medicines and healthcare products in under 30 minutes. If it scales well, it can help e-pharmacies and hospitals serve patients faster without building every delivery layer themselves.
Competitors in the market
DocPharma operates in a space connected to e-pharmacy, healthcare logistics and quick commerce. Its competitors and adjacent players include Tata 1mg, PharmEasy, Apollo 24/7, Netmeds, MedPlus, Zepto Pharmacy, and logistics platforms serving healthcare brands.
Its main difference is that it is not only a consumer-facing medicine app. It works more like an infrastructure partner for healthcare companies that need fast, reliable fulfilment.
Conclusion – Key takeaways
DocPharma’s $2 million Pre-Series A round shows growing investor interest in healthcare supply chain infrastructure.
The startup wants to make medicine delivery faster while keeping compliance and inventory reliability at the centre. The funding will help it build 100 licensed dark stores, expand to more cities, and improve its tech-led fulfilment system.
For patients, the real benefit could be simple: faster access to genuine medicines when they are needed most.
Facts Input- YS
Discover more from Newskart
Subscribe to get the latest posts sent to your email.
